dbs-paper-alternative-vams-micro-blood-sampling

the better alternative to dried blood spot collection

It's time to stop using DBS cards. Here's why!

 
Die Alternative zu den DBS-Karten

Volumetric Absorptive Microsampling (VAMS™), the technology behind Mitra® devices, retains the benefits of dried blood spot collection (DBS) cards while solving for their limitations. Overcome the hematocrit issue, with safe, accurate, and precise remote blood testing. 

case-studies-covers

Download these case studies from Exagen Diagnostics, GlaxoSmithKline, and others to see the following benefits vs DBS cards: 

  • Superior analytical performance  with better correlation to plasma

  • More simple, user-friendly dried blood collection approach
  • Compatibility with 96-well formats for fast sample extractions
  • Collect a homogeneous sample every time resulting in fewer rejects 
next-generation-dbs-device

Mitra® microsampling combines the best of traditional wet sampling and dried blood spotting in a state-of-the-art collection device..

  • Collect a fixed volume (10, 20, or 30 μL) with < 4% RSD.
  • Reduce sample rejection rates with high quality blood samples.
  • Overcome the volumetric hematocrit (HCT) effect.
  • Simple, accurate self-collection with minimal training.
  • Easily inserted into common laboratory workflows

When DBS cards debuted more than 50 years ago, they had significant advantages over traditional wet sampling, including simplicity, low cost, and ease of transportation.

But adoption has been hindered by regulatory concerns over the "Hematocrit (HCT) Effect," along with their automation limitations. In addition, incorrect spotting technique can lead to high sample rejection rates.

The FDA Class 1  Mitra® Microsampler is a novel specimen collection device that retains the advantages of DBS cards and solves for their limitations.

Drop us a line

Neoteryx, LLC

421 Amapola Ave
Torrance, CA 90501
Call us: 1 (310) 787-8747
info@neoteryx.com

The Mitra Device is a single-use, non-sterile device used as a specimen collector and for the storage and transport of blood or other biological fluids. It is designed to be used by laboratory and healthcare professionals, or end-users as a container to collect and transport blood or other biological fluids. It is not specific to any clinical test, and is not for use in diagnostic procedures. Use of the Mitra Microsampler in Laboratory Developed Tests (LDTs) requires further processing including the establishment of performance characteristics and successful validation by the laboratory in a manner consistent with CLIA and/or other regulatory requirements.
The Mitra Microsampling Device is a FDA listed Class 1 exempt device, CE-IVD self-certified in the UK and EU, a Class I IVD in Australia, and registered with Health Canada. Neoteryx operates a Quality Management System (QMS) that is based on FDA good manufacturing practices, 21 CFR 820 regulations, and ISO-13485.

Copyright © 2019 Neoteryx, LLC. All rights reserved.